Cargando…
A Drug Repurposing Approach Reveals Targetable Epigenetic Pathways in Plasmodium vivax Hypnozoites
Radical cure of Plasmodium vivax malaria must include elimination of quiescent ‘hypnozoite’ forms in the liver; however, the only FDA-approved treatments are contraindicated in many vulnerable populations. To identify new drugs and drug targets, we screened the Repurposing, Focused Rescue, and Accel...
Autores principales: | Maher, S. P., Bakowski, M. A., Vantaux, A., Flannery, E. L., Andolina, C., Gupta, M., Antonova-Koch, Y., Argomaniz, M., Cabrera-Mora, M., Campo, B., Chao, A. T., Chatterjee, A. K., Cheng, W. T., Cooper, C. A., Cottier, K., Galinski, M. R., Harupa-Chung, A., Ji, H., Joseph, S. B., Lenz, T., Lonardi, S., Matheson, J., Mikolajczak, S. A., Padin-Irizarry, V., Pan, K., Peneau, J., Prudhomme, J., Roesch, C., Ruberto, A. A., Sabnis, S. S., Saney, C. L., Sattabongkot, J., Sereshki, S., Suriyakan, S., Moeller, T., Ubalee, R., Wang, Y., Wasisakun, P., Yin, J., McNamara, C. W., Joyner, C. J., Nosten, F., Witkowski, B., Le Roch, K. G., Kyle, D. E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9915689/ https://www.ncbi.nlm.nih.gov/pubmed/36778461 http://dx.doi.org/10.1101/2023.01.31.526483 |
Ejemplares similares
-
Liver-stage fate determination in Plasmodium vivax parasites: Characterization of schizont growth and hypnozoite fating from patient isolates
por: Vantaux, Amélie, et al.
Publicado: (2022) -
Plasmodium vivax latent liver infection is characterized by persistent hypnozoites, hypnozoite-derived schizonts, and time-dependent efficacy of primaquine
por: Flannery, Erika L., et al.
Publicado: (2022) -
Characterization of the Tubovesicular Network in Plasmodium vivax Liver Stage Hypnozoites and Schizonts
por: Sylvester, Kayla, et al.
Publicado: (2021) -
Hypnozoite depletion in successive Plasmodium vivax relapses
por: Noviyanti, Rintis, et al.
Publicado: (2022) -
Identification of potent and selective N-myristoyltransferase inhibitors of Plasmodium vivax liver stage hypnozoites and schizonts
por: Rodríguez-Hernández, Diego, et al.
Publicado: (2023)